Healius

Digital And Labor Pressures Will Limit Pathology Margins And Earnings Recovery

AnalystLowTarget

Not Invested

Community Contributor

Published

18 Dec 25

Views

n/a

AnalystLowTarget's Fair Value

n/a

-30.4%

-2.6%

-30.4%

-2.6%

You can edit this narrative until Dec 19 5:05 AM. Then, changes will post as Updates.

Author's Valuation

AU$0.658.3% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

AU$0.6

58.3% overvalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

4.22%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.34%

Calculation

AU$30.39m

Earnings '28

17.73x

PE Ratio '28

AU$538.71m

Market Cap '28

AU$538.71m

Market Cap '28

726.13m

No. shares '28

AU$0.74

Share Price '28

AU$0.74 Share Price '28

Discounted to 2025 @ 7.33% p.a.

AU$0.60

Fair Value '25